Viewing StudyNCT00097500



Ignite Creation Date: 2024-05-05 @ 11:39 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00097500
Status: COMPLETED
Last Update Posted: 2015-04-07
First Post: 2004-11-24

Brief Title: Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Type 2 Diabetes Mellitus
Keywords:
Name View
diabetes View
exenatide View
exendin-4 View
Amylin View
Lilly View